Diabetology & Metabolic Syndrome - Latest Comments

Corrigendum

Chang-sheng Sheng — 2011-12-19T12:36:18Z

The following corrections should be made to our article.

1. In the footnote of Table 3, remove the following sentence entirely: "The metabolic syndrome component was defined according to the Adult Treatment Panel III criteria (ATP III) criteria [6]. For further information, see methods."

2. The title of Table 4 should be "Sensitivity analysis on the association between microalbuminuria and the metabolic syndrome or its components in subjects not taking antihypertensive medication".

In the footnote of Table 4, replace the following sentence "Adjusted for sex, age, body mass index, current smoking, current alcoholic intake and use of antihypertensive drugs (except for analyses on elevated blood pressure and in subjects not taking antihypertensive medication) and additionally for the other components of the metabolic syndrome (except for analyses on the metabolic syndrome)" with "Adjusted for sex, age, body mass index, current smoking and alcohol intake".

3. Remove "subjects" from the legend to Figure 1. The correct legend to Figure 1 should be "The prevalence of microalbuminuria by number of the metabolic syndrome components in men (closed circles) and women (open circles) separately."

4. Remove the first part of the opening sentence of the paragraph B.8.2 of the Discussion, and change it from "Although we used lower sex-specific cut-off limits to define microalbuminuria, the prevalence of microalbuminuria in our study population was slightly lower than several previous population studies in Chinese..." to "The prevalence of microalbuminuria in our study population was slightly lower than several previous population studies in Chinese..."

5. In the paragraph B.8.3 of the Discussion, remove the last sentence entirely: "Nonetheless, as exemplified in the present study, in subjects without established cardiovascular disease, such as treated hypertension might also be a significant correlate of microalbuminuria."

Table 1

Doris Mayer — 2011-12-19T12:34:11Z

Please note that insulin signaling results in GSK-3 inactivation. GSK-3 is negatively regulated by phosphorylation.

Infant Forumlas and T1DM

Chris Exley — 2010-10-05T10:51:16Z

Considering our recent publication in BMC Pediatrics (http://www.biomedcentral.com/1471-2431/10/63) on the aluminium content of infant formulas it would be extremely interesting to look at how the exposure of these infants to aluminium varied between the control and T1DM groups. We have recently shown that aluminium might have a role to play in T2DM (Ward et al.,(2008) JIB 102, 371-375; Exley et al., (2010) JIB 104, 1125-1129)while exposure to aluminium is known to produce an anaemia which is unresponsive to iron. Of course, aluminium is also a powerful pro-oxidant and one would want to be wary of situations in which the diet included high amounts of both iron and aluminium.
There is too much aluminium in infant formulas and we can only begin to understand how this might be acting synergistically with other components of diet etc.

missing letter in author 3 name and an additional space

Hekmat El Magdoub — 2010-07-15T20:58:10Z

Dear Post Publication Team,

First, I would like to express my sincere appreciation to the efforts done by Diabetology & Metabolic Syndrome team, so as to have our work presented in its final format, and published on the reputable BMC.

Second, regarding our manuscript, there are two minor comments:

1. paragraph B.9.1, third sentence: [fasting serum insulin (µ U/ml)….], I do not think there

should be a blank space between “µ” and “U”.

2. It concerns the authors names, and I hopefully wish you can have it corrected, it concerns author 3, Dr. Lamiaa N Hammad, actually her first name is “Lamiaa” with double “a” at its end, NOT “lamia”. Actually, it was our mistake, but I wish it could be corrected.

Thanks,

Hekmat El Magdoub.